NSW Passes Medicinal Cannabis Driving Reforms in a Major Step Forward for Patients
NSW Parliament has passed legislation to give eligible medicinal cannabis patients greater protection from automatic drug-driving penalties, with a new registration scheme expected to launch in late 2026 or early 2027.
For patients who rely on prescribed cannabis, the changes represent a significant step towards recognising that detecting THC does not automatically establish impairment.
However, the reforms come with strict conditions, continued roadside testing and a mandatory 24-hour driving ban after a positive roadside result.
The legislation has passed, but the new protections are not yet operating. Patients should not assume these changes apply immediately.
Under the new system, eligible drivers will need to register with Transport for NSW, provide evidence of a valid medicinal cannabis prescription and complete an online education program about cannabis and driving safety.
The scheme will be restricted to NSW unrestricted licence holders. Learner drivers, P-platers and commercial drivers will be excluded.
Police roadside drug testing will continue unchanged. Registered patients who return a positive roadside test will still receive an immediate 24-hour driving ban, while their sample is sent for laboratory analysis.
According to the NSW Government, the laboratory result will determine what happens next:
THC below 50 ng/ml: no further action.
THC at or above 50 ng/ml: a warning for the first or second detection within two years.
A third detection at or above that threshold within two years: penalties including a $722 fine and a minimum three-month licence suspension.
The threshold should not be interpreted as proof that someone is safe to drive. Drivers showing signs of impairment can still face serious driving-under-the-influence charges.
The government also says registered patients cannot have alcohol or other drugs in their system. Standard penalties will continue to apply where multiple illicit drugs are detected, and post-crash blood and urine testing will remain in place following serious crashes.
For Cannabis Club Australia, this is meaningful progress on an issue that has left patients worried about losing their licence, employment and independence while using legally prescribed medication.
But important limitations remain. A compulsory 24-hour driving ban can still disrupt work, family responsibilities and medical appointments. Patients in regional communities, where public transport options are limited, may be particularly affected.
The warning system also means repeated THC detections at or above the threshold can still lead to licence loss, without impairment being established.
CCA supports protecting road users from impaired driving while ensuring medicinal cannabis patients are treated fairly. These reforms move NSW forward, but the practical impact on patients will be the real test.
Transport for NSW is developing the registry and mandatory education module, with implementation expected in late 2026-early 2027. The system will be reviewed after one year.
